Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Paclitaxel and Cisplatin followed by CCRT in LAHNSCC
NCT00959387Phase 2Completed
- Sponsor
- Hospital de Amor
- Start
- Aug 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel oral solution, cisplatin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Hospital de Amor. Started Aug 2009; status: completed.
02
Drugs
paclitaxel oral solutioncisplatin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00959387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959387.